Evidence map›Paper›PMID 35058430›Full record

ArticleNature communications2022

Resolving the conflict between antibiotic production and rapid growth by recognition of peptidoglycan of susceptible competitors.

Harsh Maan, Maxim Itkin, Sergey Malitsky, Jonathan Friedman, Ilana Kolodkin-Gal

Abstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Establishment of anmSystems · 2026
    Article
  2. Journal of microbiology and biotechnology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Decoding the rhizosphere microbiome againstFrontiers in microbiomes · 2026
    Review
  11. Functional Characterization ofAntibiotics (Basel, Switzerland) · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. The Utilization ofMicroorganisms · 2024
    Article
  18. Frontiers in microbiology · 2024
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Harsh MaanDepartment of Molecular Genetics, Weizmann Institute of Science, 234 Herzl Street, Rehovot, Israel.
Maxim ItkinLife Science Core Facilities Weizmann Institute of Science, 234 Herzl Street, Rehovot, Israel.
Sergey MalitskyLife Science Core Facilities Weizmann Institute of Science, 234 Herzl Street, Rehovot, Israel.ORCID http://orcid.org/0000-0003-4619-7219
Jonathan FriedmanDepartment of Plant Pathology and Microbiology, The Robert H. Smith Faculty of Agriculture, Food & Environment, The Hebrew University of Jerusalem, Rehovot, Israel.ORCID http://orcid.org/0000-0001-8476-8030
Ilana Kolodkin-GalDepartment of Plant Pathology and Microbiology, The Robert H. Smith Faculty of Agriculture, Food & Environment, The Hebrew University of Jerusalem, Rehovot, Israel. ilana.kolodkin@mail.huji.ac.il.ORCID http://orcid.org/0000-0002-8464-5660

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microbial communities employ a variety of complex strategies to compete successfully against competitors sharing their niche, with antibiotic production being a common strategy of aggression. Here, by systematic evaluation of four non-ribosomal peptides/polyketide (NRPs/PKS) antibiotics produced by Bacillus subtilis clade, we revealed that they acted synergistically to effectively eliminate phylogenetically distinct competitors. The production of these antibiotics came with a fitness cost manifested in growth inhibition, rendering their synthesis uneconomical when growing in proximity to a phylogenetically close species, carrying resistance against the same antibiotics. To resolve this conflict and ease the fitness cost, antibiotic production was only induced by the presence of a peptidoglycan cue from a sensitive competitor, a response mediated by the global regulator of cellular competence, ComA. These results experimentally demonstrate a general ecological concept - closely related communities are favoured during competition, due to compatibility in attack and defence mechanisms.

Indexed as

Anti-Bacterial AgentsBacillus subtilisBiosynthetic PathwaysNucleotidesPeptidesPeptidoglycanPlanktonPolyketidesPromoter Regions, GeneticRibosomesTranscription, GeneticAnti-Bacterial AgentsNucleotidesPeptidesPeptidoglycanPolyketides

Identifiers

PMID35058430
PMCPMC8776889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.